Advertisement

Acquisition Protocols and Image Interpretation Criteria Nuclear Medicine Imaging of Infectious Diseases

  • Alberto SignoreEmail author
  • Elena Lazzeri
  • Chiara Lauri
Chapter

Abstract

Imaging infections with radiolabeled WBC requires precise strategies in order to differentiate them from sterile inflammatory conditions. Indeed, radiolabeled neutrophil, when injected into peripheral veins, has a peculiar biodistribution characterized by a short transit through the lungs (usually 30–60 min), followed by rapid accumulation into liver, spleen, and bone marrow with slow migration into infection sites. This migration process is slower in chronic, low-degree infections and faster in acute, high-degree infections, and it is believed that it is driven by the local production of chemotactic factors.

As a consequence of this biodistribution pattern, the imaging modalities, time of image acquisition, image display, and interpretation criteria should be standardized.

In this chapter, we describe the correct procedures as recently published as EANM guidelines.

Keywords

Imaging modality Radiolabeled WBC Interpretation criteria 

References

  1. 1.
    Signore A, Lauri C, Galli F. Radiolabelled probes targeting infection and inflammation for personalized medicine. Curr Pharm Des. 2014;20(14):2338–45.CrossRefGoogle Scholar
  2. 2.
    Auletta S, Riolo D, Varani M, Lauri C, Galli F, Signore A. Labelling and clinical performance of human leukocytes labelled with 99mTc-HMPAO using Leukokit with Gelofusine versus Leukokit with HES as sedimentation agent. Contrast Media Mol Imaging. 2019;2019:8p. Article ID 4368342.Google Scholar
  3. 3.
    Palestro CJ, Love C. Radionuclide imaging of musculoskeletal infection: conventional agents. Semin Musculoskelet Radiol. 2007;11:335–52.CrossRefGoogle Scholar
  4. 4.
    Sonmezoglu K, Sonmezoglu M, Halac M, Akgün I, Türkmen C, Onsel C, et al. Usefulness of 99mTc-ciprofloxacin (infection) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med. 2001;42(4):567–74.PubMedGoogle Scholar
  5. 5.
    Jutte P, Lazzeri E, Sconfienza LM, Cassar-Pullicino V, Trampuz A, Petrosillo N, et al. Diagnostic flowcharts in osteomyelitis, spondylodiscitis and prosthetic joint infection. Q J Nucl Med Mol Imaging. 2014;58:2–19.PubMedGoogle Scholar
  6. 6.
    van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJG. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3–15.CrossRefGoogle Scholar
  7. 7.
    Martín Comín J, Rodríguez Gasén A, Van de Wiele C. Nuclear medicine imaging of infections and inflammatory diseases of the abdomen. In: Signore A, Quintero AM, editors. Diagnostic imaging of infections and inflammatory diseases: a multi-disciplinary approach. New York: Wiley; 2013. p. 216–40.CrossRefGoogle Scholar
  8. 8.
    Signore A. Nuclear medicine imaging of abdominal infections and inflammation. In: Lazzeri E, Signore A, Erba PA, Prandini N, Versari A, D’Errico G, Mariani G, editors. Radionuclide imaging of infection and inflammation. A pictorial case-based atlas. Milan: Springer-Verlag; 2013. p. 229–52.CrossRefGoogle Scholar
  9. 9.
    Lauri C, AWJM G, Signore A. Leukocyte imaging of the diabetic foot. Curr Pharm Des. 2018;24(12):1270–6.CrossRefGoogle Scholar
  10. 10.
    Lauri C, Tamminga M, Glaudemans AWJM, Juárez Orozco LE, Erba PA, Jutte PC, Lipsky BA, IJzerman MJ, Signore A, Slart RHJA. Detection of osteomyelitis in the diabetic foot by imaging techniques: a systematic review and meta-analysis comparing MRI, white blood cell scintigraphy, and FDG-PET. Diabetes Care. 2017;40(8):1111–20.CrossRefGoogle Scholar
  11. 11.
    Glaudemans AWJM, Jutte PC, Cataldo MA, Cassar-Pullicino V, Gheysens O, Borens O, Trampuz A, Wörtler K, Petrosillo N, Winkler H, Signore A, Sconfienza LM. Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur J Nucl Med Mol Imaging. 2019;46(4):957–70.CrossRefGoogle Scholar
  12. 12.
    Signore A, Sconfienza LM, Borens O, Glaudemans AWJM, Cassar-Pullicino V, Trampuz A, Winkler H, Gheysens O, Vanhoenacker FMHM, Petrosillo N, Jutte PC. Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur J Nucl Med Mol Imaging. 2019;46(4):971–88.CrossRefGoogle Scholar
  13. 13.
    Locher JT, Seybold K, Andres RJ, Schubiger PA, Mach JP, Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocyte antibodies. Nucl Med Commun. 1986;7:659–70.CrossRefGoogle Scholar
  14. 14.
    Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med. 1994;35(9):1436–43.PubMedGoogle Scholar
  15. 15.
    Gratz S, Reize P, Kemke B, Kampen WU, Lusteri M, Hoffken H. Targeting of osteomyelitis with IgG and fab’ monoclonal antibodies labeled with [99mTc]: kinetic evaluations. Q J Nucl Med Mol Imaging. 2014;60:413–23.PubMedGoogle Scholar
  16. 16.
    Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)in-oxine. Inflammation/infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):835–41.  https://doi.org/10.1007/s00259-010-1393-5. Erratum in: Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1234.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):842–8.  https://doi.org/10.1007/s00259-010-1394-4. Erratum in: Eur J Nucl Med Mol Imaging.2010 Jun;37(6):1235. PubMed PMID: 20198473; PubMed Central PMCID: PMC2844965.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, Lazzeri E. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline. Eur J Nucl Med Mol Imaging. 2018;45(10):1816–31.CrossRefGoogle Scholar
  19. 19.
    Signore A, Glaudemans AW. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25(10):681–700.CrossRefGoogle Scholar
  20. 20.
    Glaudemans AW, de Vries EF, Vermeulen LE, Slart RH, Dierckx RA, Signore A. A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with 99mTc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imaging. 2013;40(11):1760–9.CrossRefGoogle Scholar
  21. 21.
    Erba PA, Glaudemans AW, Veltman NC, Sollini M, Pacilio M, Galli F, Dierckx RA, Signore A. Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study. Eur J Nucl Med Mol Imaging. 2014;41(4):615–23.CrossRefGoogle Scholar
  22. 22.
    Erba PA, Leo G, Sollini M, Tascini C, Boni R, Berchiolli RN, Menichetti F, Ferrari M, Lazzeri E, Mariani G. Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. Eur J Nucl Med Mol Imaging. 2014;41(2):357–68.CrossRefGoogle Scholar
  23. 23.
    Signore A, Quintero AM. Diagnostic imaging of infections and inflammatory diseases: a multi-disciplinary approach. New York: Wiley; 2013.CrossRefGoogle Scholar
  24. 24.
    Grippaudo FR, Pacilio M, Di Girolamo M, Dierckx RA, Signore A. Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications. Eur J Nucl Med Mol Imaging. 2013;40(3):418–25.CrossRefGoogle Scholar
  25. 25.
    Pelosi E, Baiocco C, Pennone M, Migliaretti G, Varetto T, Maiello A, et al. 99mTc-HMPAO-leukocyte scintigraphy in patients with symptomatic total hip or knee arthroplasty: improved diagnostic accuracy by means of semiquantitative evaluation. J Nucl Med. 2004;45(3):438–44.PubMedGoogle Scholar
  26. 26.
    Wang SJ, Kao CH, Chen DU, Lin MS, Yeh SH, Lan JL. Quantitative 99mTc-HMPAO white blood cells and 67Ga scanning in rheumatoid arthritis. Nucl Med Commun. 1991;12(6):551–8.CrossRefGoogle Scholar
  27. 27.
    Glaudemans AW, Galli F, Pacilio M, Signore A. Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater. 2013;25:61–77.CrossRefGoogle Scholar
  28. 28.
    Palestro C, Swyer A, Kim C, Goldsmith S. Infected knee prosthesis: diagnosis with in-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology. 1991;179(3):645–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine“Sapienza” University of RomeRomeItaly
  2. 2.Regional Center of Nuclear MedicinePisa University HospitalPisaItaly

Personalised recommendations